Kala Bio Inc (KALA)
6.59
-0.14
(-2.08%)
USD |
NASDAQ |
May 17, 16:00
6.59
0.00 (0.00%)
After-Hours: 20:00
Kala Bio Max Drawdown (5Y): 99.59% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.59% |
| March 31, 2024 | 99.59% |
| February 29, 2024 | 99.59% |
| January 31, 2024 | 99.59% |
| December 31, 2023 | 99.59% |
| November 30, 2023 | 99.59% |
| October 31, 2023 | 99.59% |
| September 30, 2023 | 99.59% |
| August 31, 2023 | 99.59% |
| July 31, 2023 | 99.59% |
| June 30, 2023 | 99.59% |
| May 31, 2023 | 99.59% |
| April 30, 2023 | 99.59% |
| March 31, 2023 | 99.59% |
| February 28, 2023 | 99.59% |
| January 31, 2023 | 99.59% |
| December 31, 2022 | 99.59% |
| November 30, 2022 | 99.43% |
| October 31, 2022 | 99.36% |
| September 30, 2022 | 98.88% |
| August 31, 2022 | 98.88% |
| July 31, 2022 | 98.88% |
| June 30, 2022 | 98.87% |
| May 31, 2022 | 98.69% |
| April 30, 2022 | 97.70% |
| Date | Value |
|---|---|
| March 31, 2022 | 97.70% |
| February 28, 2022 | 97.68% |
| January 31, 2022 | 97.09% |
| December 31, 2021 | 95.63% |
| November 30, 2021 | 93.48% |
| October 31, 2021 | 93.48% |
| September 30, 2021 | 90.12% |
| August 31, 2021 | 89.60% |
| July 31, 2021 | 87.34% |
| June 30, 2021 | 87.34% |
| May 31, 2021 | 87.34% |
| April 30, 2021 | 87.34% |
| March 31, 2021 | 87.34% |
| February 28, 2021 | 87.34% |
| January 31, 2021 | 87.34% |
| December 31, 2020 | 87.34% |
| November 30, 2020 | 87.34% |
| October 31, 2020 | 87.34% |
| September 30, 2020 | 87.34% |
| August 31, 2020 | 87.34% |
| July 31, 2020 | 87.34% |
| June 30, 2020 | 87.34% |
| May 31, 2020 | 87.34% |
| April 30, 2020 | 87.34% |
| March 31, 2020 | 87.34% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
83.83%
Minimum
May 2019
99.59%
Maximum
Dec 2022
93.08%
Average
93.48%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| CEL-SCI Corp | 96.13% |
| AIM ImmunoTech Inc | 99.76% |
| IGC Pharma Inc | 97.77% |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -38.04 |
| Beta (5Y) | -1.745 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 228.4% |
| Historical Sharpe Ratio (5Y) | -0.2517 |
| Historical Sortino (5Y) | -1.179 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.35% |